Open Access

Poster Session 7 - Acute Coronary Syndromes - Treatment antiplatelet

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 3 September 2019

Session

10 presentations in this session

Ischemic and bleeding events during dual antiplatelet therapy after second-generation drug-eluting stent implantation in hemodialysis patients: a propensity score-matched analysis

Speaker: Doctor A. Shimizu (Kitakyushu, JP)
Thumbnail

Predictors of bleeding in elderly patients with myocardial infarction: data from the real world

Speaker: Doctor S. Alegria (Almada, PT)
Thumbnail

Myocardial infarction with nonobstructive coronary arteries: does aspirin have a place in the treatment of this entity?

Speaker: Doctor J. Ferreira (Coimbra, PT)
Thumbnail

Potential for drug-drug interaction between vonoprazan and prasugrel on antiplatelet effect assessed by VerifyNow P2Y12 assay in patients with coronary artery disease

Speaker: Doctor S. Koga (Tokyo, JP)
Thumbnail

Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome

Speaker: Doctor F. Scudiero (Seriate, IT)
Thumbnail

Potential benefit of ticagrelor monotherapy for patients with hypertension undergoing percutaneous coronary intervention: Insights from the Global Leaders trial

Speaker: Doctor R. Modolo (Campinas, BR)
Thumbnail

Ticagrelor and prasugrel versus clopidogrel in patients with acute coronary syndromes and chronic renal dysfunction: safety and efficacy

Speaker: Doctor O. De Filippo (Turin, IT)
Thumbnail

Eligibility and preference of extended antithrombotic therapy for secondary prevention after an acute coronary syndrome

Speaker: Doctor D. Candeias Faria (Amadora, PT)
Thumbnail

Dyspnea in ticagrelor treated patients in the all-comer randomized GLOBAL LEADERS study and its association with clinical outcomes

Speaker: Doctor M. Tomaniak (Rotterdam, NL)
Thumbnail

The AKR1D1*36 (rs1872930) allelic variant is independently associated with adverse cardiac events during Clopidogrel treatment

Speaker: Doctor P. Ugurov (Skopje, MK)
Thumbnail

10 speakers from this session

Doctor Akiyoshi Shimizu

University of Occupational and Environmental Health, Kitakyushu (Japan)
0 follower

Doctor Sofia Alegria

Hospital Garcia de Orta, Almada (Portugal)
1 presentation
0 follower

Doctor Joao Ferreira

University Hospitals of Coimbra, Coimbra (Portugal)
2 presentations
0 follower

Doctor Seiji Koga

Juntendo University Nerima Hospital, Tokyo (Japan)
0 follower

Doctor Fernando Scudiero

BOLOGNINI HOSPITAL - SERIATE, Seriate (Italy)
0 follower

Doctor Rodrigo Modolo

State University of Campinas (UNICAMP), Campinas (Brazil)
0 follower

Doctor Ovidio De Filippo

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)
0 follower

Doctor Daniel Alexandre Candeias Faria

Hospital Prof Fernando da Fonseca EPE, Amadora (Portugal)
2 presentations
0 follower

Doctor Mariusz Tomaniak

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
0 follower

Doctor Petar Ugurov

Special Hospital for Surgical Diseases Filip II, Skopje (North Macedonia)
0 follower

This platform is supported by

logo Novo Nordisk